Table 3. The clinical and biochemical characteristics of TNFSF4 rs3850641 polymorphism among two groups.
| Patients (N=454) | Controls (N=512) | |||||||
|---|---|---|---|---|---|---|---|---|
| AA (N=300) | AG (N=128) | GG (N=25) | P | AA (N=360) | AG (N=135) | GG (N=15) | P | |
| Age (years) | 60.92 ± 10.51 | 61.84 ± 11.51 | 58.72 ± 10.75 | 0.392 | 61.08 ± 11.03 | 60.47 ± 11.08 | 63.87 ± 9.96 | 0.512 |
| BMI (kg/m2) | 27.65 ± 3.08 | 27.99 ± 3.01 | 28.06 ± 3.83 | 0.514 | 25.63 ± 3.17 | 25.07 ± 3.08 | 26.11 ± 2.67 | 0.167 |
| TC (mmol/l) | 4.84 ± 1.06 | 4.77 ± 1.06 | 4.67 ± 0.89 | 0.648 | 4.52 ± 1.05 | 4.48 ± 1.03 | 4.76 ± 1.09 | 0.622 |
| HDL (mmol/l) | 1.13 ± 0.31 | 1.12 ± 0.34 | 1.13 ± 0.43 | 0.987 | 1.62 ± 0.39 | 1.61 ± 0.39 | 1.56 ± 0.48 | 0.839 |
| LDL (mmol/l) | 2.94 ± 0.89 | 2.81 ± 0.85 | 2.78 ± 1.00 | 0.309 | 2.69 ± 0.75 | 2.71 ± 0.77 | 2.70 ± 0.58 | 0.967 |
Abbreviations: BMI, body mass index; HDL, high-density lipoprotein; LDL, low-density lipoprotein; TC, total cholesterol.